EP3797098A4 - Solid oral pharmaceutical compositions comprising phenyramidol or salts thereof - Google Patents

Solid oral pharmaceutical compositions comprising phenyramidol or salts thereof Download PDF

Info

Publication number
EP3797098A4
EP3797098A4 EP18939823.3A EP18939823A EP3797098A4 EP 3797098 A4 EP3797098 A4 EP 3797098A4 EP 18939823 A EP18939823 A EP 18939823A EP 3797098 A4 EP3797098 A4 EP 3797098A4
Authority
EP
European Patent Office
Prior art keywords
phenyramidol
salts
pharmaceutical compositions
solid oral
oral pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18939823.3A
Other languages
German (de)
French (fr)
Other versions
EP3797098A1 (en
Inventor
Ersin Yildirim
Bayram Kanik
Tansel AKTA
Fatma ÖZTÜRK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santa Farma Ilac Sanayi AS
Original Assignee
Santa Farma Ilac Sanayi AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santa Farma Ilac Sanayi AS filed Critical Santa Farma Ilac Sanayi AS
Publication of EP3797098A1 publication Critical patent/EP3797098A1/en
Publication of EP3797098A4 publication Critical patent/EP3797098A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
EP18939823.3A 2018-11-16 2018-11-16 Solid oral pharmaceutical compositions comprising phenyramidol or salts thereof Pending EP3797098A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/TR2018/050697 WO2020101585A1 (en) 2018-11-16 2018-11-16 Solid oral pharmaceutical compositions comprising phenyramidol or salts thereof

Publications (2)

Publication Number Publication Date
EP3797098A1 EP3797098A1 (en) 2021-03-31
EP3797098A4 true EP3797098A4 (en) 2021-12-29

Family

ID=70730865

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18939823.3A Pending EP3797098A4 (en) 2018-11-16 2018-11-16 Solid oral pharmaceutical compositions comprising phenyramidol or salts thereof

Country Status (2)

Country Link
EP (1) EP3797098A4 (en)
WO (1) WO2020101585A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792410B2 (en) * 1967-09-01 1980-03-13 Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm Medicinal preparation for intravenous injection
US20090182016A1 (en) * 2006-05-23 2009-07-16 Anupama Datla Optical enantiomers of phenyramidol and process for chiral synthesis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
WO2020101585A1 (en) 2020-05-22
EP3797098A1 (en) 2021-03-31

Similar Documents

Publication Publication Date Title
EP3829554A4 (en) Solid self-emulsifying pharmaceutical compositions
EP3817722A4 (en) Pharmaceutical compositions comprising meloxicam
EP3709978B8 (en) Pharmaceutical oral formulation comprising bacteria
EP3565532A4 (en) Oral dispersible film composition
EP3768675A4 (en) Novel triazolone derivatives or salts thereof and pharmaceutical compositions comprising the same
EP3894408A4 (en) Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same
EP4043002A4 (en) Dental composition
EP3781135A4 (en) Solid oral pharmaceutical compositions comprising sitagliptin
EP3851121A4 (en) Human anti-il-33 monoclonal-antibody-containing pharmaceutical composition
EP3866767A4 (en) Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt
EP3746078A4 (en) Oral formulations and uses thereof
EP3895682A4 (en) Dental composition
IL290469A (en) Oral pharmaceutical composition
EP3868371A4 (en) Novel pharmaceutical composition
EP3756471A4 (en) Oral ingestion composition
EP3701930A4 (en) Dental composition
EP3881841A4 (en) Pharmaceutical composition
EP3813822A4 (en) Solid oral pharmaceutical compositions comprising teriflunomide
EP3873437A4 (en) Aqueous pharmaceutical formulations
EP3801539A4 (en) Solid oral pharmaceutical compositions of linagliptin
PT3632436T (en) Pharmaceutical composition comprising lenvatinib salts
EP3459555A4 (en) Composition for oral cavity
EP3811787A4 (en) Oral composition
EP3979980A4 (en) Oral care composition
EP3984549A4 (en) Medicinal composition

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201221

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

A4 Supplementary search report drawn up and despatched

Effective date: 20211201

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 21/02 20060101ALI20211125BHEP

Ipc: A61K 31/4402 20060101ALI20211125BHEP

Ipc: C07D 213/74 20060101AFI20211125BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)